Protease activated receptor 2 and the cardiovascular system
- 29 January 2002
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 135 (1), 14-20
- https://doi.org/10.1038/sj.bjp.0704438
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Pharmacological dissection of vascular effects caused by activation of protease‐activated receptor 1 and 2 in anesthetized ratsThe FASEB Journal, 2001
- Factor Xa Activates Endothelial Cells by a Receptor Cascade Between EPR-1 and PAR-2Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Evidence for Selective Effects of Chronic Hypertension on Cerebral Artery Vasodilatation to Protease-Activated Receptor-2 ActivationStroke, 1999
- Activation of Protease-Activated Receptor-2 (PAR-2) Elicits Nitric Oxide–Dependent Dilatation of the Basilar Artery In VivoStroke, 1998
- Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo.Journal of Clinical Investigation, 1998
- Receptor-activating peptides distinguish thrombin receptor (PAR-1) and protease activated receptor 2 (PAR-2) mediated hemodynamic responses in vivoCanadian Journal of Physiology and Pharmacology, 1998
- Ligand Cross-reactivity within the Protease-activated Receptor FamilyJournal of Biological Chemistry, 1996
- Protease activated receptors modulate aortic vascular toneInternational Journal of Cardiology, 1996
- Modulators of coagulation. A critical appraisal of their role in sepsisArchives of Internal Medicine, 1992
- Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activationCell, 1991